دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Bipolar Endo-Epicardial Radiofrequency Ablation of Therapy-Resistant Ventricular Arrhythmias: A Brief Case Series
Pawe? Derejko, MD, PH D, a,b Jacek Kusnierz, MD,b Aleksander Bardyszewski, MD, b Dobromi?a Dzwonkowska, MD,b Magdalena Polanska-Skrzypczyk, MD, b ?ukasz Jan Szumowski, MD, P HD, a Atul Verma, MD
doi : 10.1016/j.jacep.2023.02.026
Volume 9, Issue 6, June 2023, Pages 733-737
Despite extensive conventional endoepicardial ablation, significant intramural arrhythmogenic substrate may remain out of reach of unipolar radiofrequency ablation (RFA).
Bipolar Ablation: The Perfect Recipe for a Well-Done Endo-Epicardial Lesion Set∗
Piotr Futyma, MD, PHD, a,b Piotr Ku?akowski, MD, PHD
doi : 10.1016/j.jacep.2023.05.012
Volume 9, Issue 6, June 2023, Pages 738-739
Head-to-Head Comparison of T1 Mapping and Electroanatomical Voltage Mapping in Patients With Ventricular Arrhythmias
Marek Sramko, MD, PH D, a,b, * Saif Abdel-Kafi, MD,c,d, * Adrianus P. Wijnmaalen, MD, PH D, c,d Qian Tao, PH D, e Rob J. van der Geest, PH D, f Hildo J. Lamb, MD, PH D, g Katja Zeppenfeld, MD, P HD
doi : 10.1016/j.jacep.2022.10.035
Volume 9, Issue 6, June 2023, Pages 740-748
Electroanatomical voltage mapping (EAVM) has been compared with late gadolinium enhancement cardiovascular magnetic resonance (LGE-CMR), which cannot delineate diffuse fibrosis. T1-mapping CMR overcomes the limitations of LGE-CMR, but it has not been directly compared against EAVM.
T1 Mapping: A Complementary Tool for Substrate Visualization∗
Justin Hayase, MD, Jason Bradfield, MD
doi : 10.1016/j.jacep.2023.01.038
Volume 9, Issue 6, June 2023, Pages 749-750
T1 Mapping for Identifying the Substrate in Patients With Apparently Idiopathic Premature Ventricular Complexes
Shiqin Yu, MD,a, * Xiuyu Chen, MD, P HD, a, * Zhixiang Dong, MD, a Huaibing Cheng, MD, PHD, b Kai Yang, MD, PH D, a Gang Yin, MM ED ,a Shujuan Yang, MD, a Wenhao Dong, BS, a Minjie Lu, MD, P HD, a Likun Ma, MD, PH D, c Shihua Zhao, MD, PHD a
doi : 10.1016/j.jacep.2022.12.012
Volume 9, Issue 6, June 2023, Pages 751-761
Shifty Protons and the Compensatory Pause∗
Benjamin Levin, MD, Charles A. Henrikson, MD
doi : 10.1016/j.jacep.2023.01.027
Volume 9, Issue 6, June 2023, Pages 762-764
Biophysical Tissue Characterization of Ventricular Tachycardia Substrate With Local Impedance Mapping to Predict Critical Sites
J?lia Arany?, MD, a,b Daina Mart?nez-Falguera, BSC ,c,d V?ctor Bazan, MD, PHD, a,b Edgar Fadeuilhe, MD,a Albert Teis, MD,a,c,e Axel Sarrias, MD,a Oriol Rodr?guez-Leor, MD, PH D, a,e Carolina Curiel, BSC ,f Roger Villuendas, MD, PHD, a,e Antoni Bayés-Gen?s, MD, PH D, a,b,c,e,g Carolina G?lvez-Mont?n, DVM, PHD, a,c, * Felipe Bisbal, MD, PH D
doi : 10.1016/j.jacep.2022.11.023
Volume 9, Issue 6, June 2023, Pages 765-775
New tools are needed to improve ventricular tachycardia (VT) substrate characterization and optimize outcomes. LI provides biophysical tissue characterization.
A New Look at Impedance in the Electrophysiology Laboratory: Local Tissue Impedance to Identify VT Substrate∗
Cory M. Tschabrunn, P HD, David J. Callans, MD
doi : 10.1016/j.jacep.2023.01.002
Volume 9, Issue 6, June 2023, Pages 776-778
Evolution of Deceleration Zones During Ventricular Tachycardia Ablation and Relation With Cardiac Magnetic Resonance
Sara V?zquez-Calvo, MD, a,b Judit Mas Casanovas, BE NG ,a Paz Garre, BE NG, a,b Elisenda Ferr?, BE NG, a,b Paula S?nchez-Somonte, MD,a,b Levio Quinto, MD, a,b Eduard Guasch, MD, PHD, a,b,c Andreu Porta-Sanchez, MD, PH D, a,b José Maria Tolosana, MD, PHD, a,b,c Roger Borras, MS C, a,b Elena Arbelo, MD, P HD, a,b,c José T. Ortiz-Pérez, MD, PHD, a,b,c Josep Brugada, MD, PH D, a,b,c Llu?s Mont, MD, PHD, a,b,c Ivo Roca-Luque, MD, P HD
doi : 10.1016/j.jacep.2022.12.015
Volume 9, Issue 6, June 2023, Pages 779-789
A new functional mapping strategy based on targeting deceleration zones (DZs) has become one of the most commonly used strategies within the armamentarium of substrate-based ablation methods for ventricular tachycardia (VT) in patients with structural heart disease. The classic conduction channels detected by voltage mapping can be accurately determined by cardiac magnetic resonance (CMR).
Adverse Prognosis of Patients With Septal Substrate After VT Ablation Due to Electrical Storm
Julian Mueller, MD,a,b,c Ivaylo Chakarov, MD, a Philipp Halbfass, MD,b,d Karin Nentwich, MD, a,b Elena Ene, MD,a Artur Berkovitz, MD,a Kai Sonne, MD, a Sebastian Barth, MD,a,b Christian Waechter, MD, b Michael Behnes, MD, c Ibrahim Akin, MD,c Stefan Fodor, MD, e Lukas Lehmkuhl, MD,e Thomas Deneke, MD
doi : 10.1016/j.jacep.2023.01.012
Volume 9, Issue 6, June 2023, Pages 790-804
Data about ventricular tachycardia (VT) ablation in patients with electrical storm (ES) is limited.
Septal Substrate in Ventricular Tachycardia Storm: Bellwether of Risk∗
Neal A. Chatterjee, MD, MSC
doi : 10.1016/j.jacep.2023.03.012
Volume 9, Issue 6, June 2023, Pages 805-807
Ventricular Tachycardia and ICD Therapy Burden With Catheter Ablation Versus Escalated Antiarrhythmic Drug Therapy
Michelle Samuel, MPH, PHD, a Jeff S. Healey, MD,b Isabelle Nault, MD,c Laurence D. Sterns, MD,d Vidal Essebag, MD, PH D, e,f Christopher Gray, MD, g Tomasz Hruczkowski, MD, h Martin Gardner, MD,g Ratika Parkash, MD,g John L. Sapp, MD
doi : 10.1016/j.jacep.2023.01.030
Volume 9, Issue 6, June 2023, Pages 808-821
Catheter ablation improves ventricular tachycardia (VT) event-free (time to event) survival in patients with antiarrhythmic drug (AAD)-refractory VT and previous myocardial infarction (MI). The effects of ablation on recurrent VT and implantable cardioverter-defibrillator (ICD) therapy (burden) have yet to be investigated.
Insanity and the Law of Diminishing Returns∗
Harikrishna Tandri, MD
doi : 10.1016/j.jacep.2023.05.017
Volume 9, Issue 6, June 2023, Pages 822-823
Causes of Early Mortality After Ventricular Tachycardia Ablation in Patients With Reduced Ejection Fraction
Justin Z. Lee, MD, a Min-Choon Tan, MD, a Suganya Karikalan, MBBS, a Abhishek J. Deshmukh, MD,a Komandoor Srivathsan, MD,a Win K. Shen, MD, a Hicham El-Masry, MD, a Luis Scott, MD,a Samuel J. Asirvatham, MD, b Yong-Mei Cha, MD, b Christopher J. McLeod, MBC HB, PHD, c Siva K. Mulpuru, MD
doi : 10.1016/j.jacep.2022.10.024
Volume 9, Issue 6, June 2023, Pages 824-832
Recognition of the causes of early mortality after ventricular tachycardia (VT) ablation in patients with reduced left ventricular ejection fraction (LVEF) is an essential step toward improving postprocedural outcomes.
Early Mortality After VT Ablation: “The Remedy Worse Than the Disease�?∗
Lars Eckardt, MD, PH D, a Stephan Willems, MD, P HD
doi : 10.1016/j.jacep.2022.11.004
Volume 9, Issue 6, June 2023, Pages 833-835
Matching Ablation Endpoints to Long-Term Outcome: The Prospective Multicenter Italian Ventricular Tachycardia Ablation Registry
Andrea Radinovic, MD,a Giovanni Peretto, MD,a Giuseppe Sgarito, MD, P HD, b Filippo Maria Cauti, MD, c Antonello Castro, MD, d Maria Lucia Narducci, MD, PHD, e Roberto Mantovan, MD, f Marco Scaglione, MD,g Francesco Solimene, MD, h Alice Scopinaro, MD, i Claudio Tondo, MD, P HD, j Giulia Filippini, MD, k Elisabetta Bianco, MD,l Aldo Bonso, MD, m Vittorio Calzolari, MD,n Federico Ferraris, MD, o Marco Zardini, MD,p Marcello Piacenti, MD, q Giuseppe D’Angelo, MD,a Francesco Bosica, PHD, a Paolo Della Bella, MD
doi : 10.1016/j.jacep.2022.10.038
Volume 9, Issue 6, June 2023, Pages 836-847
Multicenter ventricular tachycardia (VT) ablation studies have shown poorer outcomes compared with single-center experiences. This difference could be related to heterogeneous mapping and ablation strategies.
A Further Step Toward the Spread of Ventricular Tachycardia Substrate Ablation During Stable Rhythm∗
Antonio Berruezo, MD, PHD, Giulio Falasconi, MD, Diego Penela, MD, PH D
doi : 10.1016/j.jacep.2022.12.013
Volume 9, Issue 6, June 2023, Pages 848-850
Lateral Boundaries of the Ventricular Tachycardia Circuit Align With Sinus Rhythm Discontinuities
Edward J. Ciaccio, PH D, a,b James Coromilas, MD,c Elaine Y. Wan, MD,a Hirad Yarmohammadi, MD,a Deepak S. Saluja, MD, a Nicholas S. Peters, MD, P HD, b Hasan Garan, MD,a Angelo B. Biviano, MD
doi : 10.1016/j.jacep.2022.11.037
Volume 9, Issue 6, June 2023, Pages 851-861
Sinus rhythm electrical activation mapping can provide information regarding the ischemic re-entrant ventricular tachycardia (VT) circuit. The information gleaned may include the localization of sinus rhythm electrical discontinuities, which can be defined as arcs of disrupted electrical conduction with large activation time differences across the arc.
Electrical Discontinuities in Sinus Rhythm: Is the Isthmus Set?∗
Joshua Hawson, MBBS,a,b Geoffrey Lee, MBC HB, PHD
doi : 10.1016/j.jacep.2022.12.023
Volume 9, Issue 6, June 2023, Pages 862-864
Sudden Cardiac Death During Exercise in Young Individuals With Hypertrophic Cardiomyopathy
Gherardo Finocchiaro, MD, PhDy Raghav T. Bhatia, MBBSJoseph Westaby, MBBS, PhD Elijah R. Behr, MA, MBBS, MD Michael Papadakis, MBBS, MD Sanjay Sharma, BSc, MBChB, MD *Mary N. Sheppard, MBBCh, BAO, BSc, MD
doi : 10.1016/j.jacep.2022.12.007
Volume 9, Issue 6, June 2023, Pages 865-867
Effect of Additionally Integrating Clinical Information Into the Brugada Algorithm
Federico Moccetti, MD Pedro Brugada, MD Gregorio Tersalvi, MD Mrinal Yadava, MD Yllka Latifi, MD Benjamin Berte, MD Richard Kobza, MD Christian Sticherling, MD *Tobias Reichlin, MD
doi : 10.1016/j.jacep.2022.12.017
Volume 9, Issue 6, June 2023, Pages 868-870
Hyperventilation Before Apneic Oxygenation During Pulmonary Vein Isolation May Be Unnecessary and Potentially Harmful
Maximilian S. Schaefer, MD, PhD Elena Ahrens, Cand Med Tracy Butler, MD
doi : 10.1016/j.jacep.2023.04.029
Volume 9, Issue 6, June 2023, Page 871
Reply: Hyperventilation Prior to Apneic Oxygenation During Pulmonary Vein Isolation May Be Unnecessary and Potentially Harmful
James K. Gabriels, MD Diana Anca, MD *Apoor Patel, MD yJim W. Cheung, MD
doi : 10.1016/j.jacep.2023.05.002
Volume 9, Issue 6, June 2023, Page 872
Catheter Ablation vs Antiarrhythmic Drug Therapy for Treatment of Premature Ventricular Complexes: A Systematic Review
Kasun De Silva, MD, a,b Haris Haqqani, MBBS, PH D, c,d Rajiv Mahajan, MD, PH D, e Pierre Qian, MBBS, PHD, a,b William Chik, MBBS, PH D, a Aleksandr Voskoboinik, MBBS, PH D, f Peter M. Kistler, MBBS, P HD, f,g,h Geoffrey Lee, MBC HD, PH D, i Nicholas Jackson, MBBS,j,k Saurabh Kumar, MBBS, P HD
doi : 10.1016/j.jacep.2023.01.035
Volume 9, Issue 6, June 2023, Pages 873-885
There is variability in treatment modalities for premature ventricular complexes (PVCs), including use of antiarrhythmic drug (AAD) therapy or catheter ablation (CA). This study reviewed evidence comparing CA vs AADs for the treatment of PVCs.
Fatal Complication of Endo-Epicardial Bipolar Radiofrequency Ablation During Animal Experiment: A Warning for Clinical Electrophysiologist?
Piotr Kulakowski, MD, P HD, a Pawel Derejko, MD, P HD, b,c Jacek Kusnierz, MD, P HD, b Jakub Baran, MD, P HD, a Urszula Hangiel, BS C, MPH, d Izabela Janus, MVD, PH D, e Agnieszka Noszczyk-Nowak, MVD, P HD
doi : 10.1016/j.jacep.2023.01.001
Volume 9, Issue 6, June 2023, Pages 886-888
2 Ventricular Tachycardias Shared Single Critical Isthmus in a Patient With Idiopathic Left Ventricular Aneurysm
Ruya Zhou, MD, Yifan Chen, MD, Xiaoyan Wu, MD, Xiang Mao, MD, Mengting Yang, MD, Jiafeng Lin, MD, Jia Li, MD, PH D
doi : 10.1016/j.jacep.2023.01.004
Volume 9, Issue 6, June 2023, Pages 889-891
